eNOS activator-1
eNOS activator-1 is an orally active, blood-brain barrier permeable endothelial nitric oxide synthase (eNOS) activator. eNOS activator-1 upregulates eNOS mRNA expression, enhances endogenous NO biosynthesis, and activates the eNOS signaling pathway to maintain blood-brain barrier integrity. eNOS activator-1 upregulates the protein expression levels of PI3K, AKT, p-PI3K, and p-AKT. eNOS activator-1 reduces oxidative stress levels by decreasing lipid peroxidation and restoring antioxidant enzyme activities. eNOS activator-1 upregulates the expression of tight junction proteins ZO-1 and occludin, increases Cav-1 expression, and inhibits MMP-9-mediated blood-brain barrier disruption. eNOS activator-1 can be used in the research of ischemic stroke.
For research use only. We do not sell to patients.
- Formula: C14H15NO6
- Molecular Weight:293.27
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
eNOS |
PI3K |
Akt |
MMP-9 |
ZO-1 |
Cav-1 |
In Vitro
eNOS activator-1 (1.8-60 μM; 24 h) shows no detectable cytotoxicity in primary rat neuronal cells at concentrations as high as 60 μM[1].
eNOS activator-1 (50 μg/mL; 18 h at 25 °C) demonstrates excellent predicted passive blood-brain barrier permeability in the in vitro PAMPA assay[1].
eNOS activator-1 (0.9-30 μM) exerts strong and consistent neuroprotective activity against oxygen-glucose deprivation/reperfusion injury in primary rat cortical neurons[1].
eNOS activator-1 (0.005 mM; 1-10 h) releases a stable, low concentration of NO over a 10 hour in vitro incubation[1].
eNOS activator-1 (compound 10) exerts an in vitro blood-brain barrier protective effect in primary rat neuronal OGD/R cultures that is fully dependent on eNOS activation, which regulates downstream Cav-1 and MMP-9 signaling[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Rat primary neuronal cells
-
Concentration:1.8-60 μM
-
Incubation Time:24 h
-
Result:Show no detectable cytotoxicity at concentrations up to 60 μM, with full retention of cell viability across the tested concentration range.
In Vivo
eNOS activator-1 (20-40 mg/kg; p.o.; single pretreatment 2 hours before MCAO then once daily; 6 consecutive days after surgery) exerts potent neuroprotective, anti-inflammatory, antioxidant, and BBB-preserving effects in the rat MCAO/R ischemic stroke model, reducing infarct volume to as low as 24.1% at the 40 mg/kg dose[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:KM mice (male, 18-22 g, 22 days old)[1]
-
Dosage:200 mg/kg; 400 mg/kg
-
Administration:p.o.; daily; 7 consecutive days
-
Result:Showed no acute neurological toxicities including tremor, convulsion, or death over the 7-day observation period.
Exhibited no difference in average body weight compared to the control group.
Demonstrated good tolerance at a daily dose of 400 mg/kg with a total accumulated dosage of 2.8 g/kg.
-
Animal Model:Sprague-Dawley rats (male, 200-220 g)[1]
-
Dosage:20 mg/kg; 40 mg/kg
-
Administration:p.o.; single pretreatment 2 hours before MCAO then once daily; 6 consecutive days after surgery
-
Result:Reduced infarct volume to 29.0% at the 20 mg/kg dose.
Reduced infarct volume to 24.1% at the 40 mg/kg dose.
Alleviated histopathological neuronal damage and restored normal neuronal and capillary morphology.
Dose-dependently reduced IL-6 levels and restored reduced IL-10 levels.
Suppressed activation of Iba-1+ microglia and GFAP+ astrocytes, decreased M1 (CD86+) microglia and increased M2 (CD206+) microglia polarization.
Reversed the MCAO/R-induced increase in MDA and decrease in SOD levels.
Upregulated expression of PI3K, AKT, p-PI3K, and p-AKT proteins.
Reduced Evans blue extravasation to preserve BBB integrity, upregulated expression of tight junction proteins ZO-1 and occludin, increased Cav-1 expression, decreased MMP-9 levels.
Significantly elevated eNOS mRNA expression at the 40 mg/kg dose.
Chemical Information
-
Molecular Weight 293.27
-
Formula C14H15NO6
-
SMILES
O=[N+]([O-])OCCOC1=CC=C2C(/C(OC2=C1)=C/CCC)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RT-PCR
Reverse transcription technology uses RNA as a template to synthesize DNA. RT-PCR is simple, specific and sensitive, and can be used to detect gene expression levels and expression differences in cells; detect RNA virus content; clone cDNA sequences of specific genes.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Real Time qPCR (Q-PCR)
Real-time quantitative PCR (qPCR) quantifies an amplifiable nucleic-acid target by monitoring fluorescence during PCR cycling rather than measuring product only after amplification. The increase in fluorescence tracks accumulation of PCR product, and the quantification cycle (Cq; historically also Ct/CP) is related to the initial amount of target: samples containing more starting target generally reach the defined fluorescence threshold in fewer cycles.
-
Protocol For Protein Expression And Purification
Recombinant protein expression in Escherichia coli followed by purification of a His-tagged soluble protein by immobilized metal affinity chromatography (IMAC), with optional MBP fusion and TEV tag removal when the construct includes these elements. The biological readout is production of the encoded target protein, detected as an inducible band at the expected molecular mass by SDS-PAGE and quantified by total protein assay or chromatographic absorbance; the purification readout is enrichment of the target protein in elution fractions after selective binding of polyhistidine residues to immobilized Ni2+/metal-chelate resin and elution by imidazole-containing buffer. Expression is driven by an inducible bacterial expression system, commonly T7/lac-based, in which IPTG or lactose/auto-induction activates transcription and translation of the cloned gene; lower induction temperature, lower inducer concentration, induction timing, and solubility-enhancing fusion tags can influence the frac
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)